ArticleFrontiers in pain research (Lausanne, Switzerland)2026
The unheard pain: why patient-related barriers remain the weakest link in cancer pain management.
Article in Frontiers in pain research (Lausanne, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer pain remains a major challenge in oncology and palliative care despite the availability of clinical guidelines, effective analgesics, opioids, educational interventions, and non-pharmacological strategies. This Perspective argues that patient-related barriers remain one of the weakest links in cancer pain management because they are often treated as secondary obstacles rather than core determinants of treatment effectiveness. These barriers include fear of addiction, concerns about adverse effects, fatalistic beliefs, limited pain communication, low adherence, insufficient knowledge, and difficulties integrating pain management strategies into everyday life. Rather than framing these barriers as mere individual misconceptions, this article interprets them as interpretive-relational barriers that emerge from the interaction among personal beliefs, cultural meanings, emotional responses, clinical communication gaps, and health system limitations. Effective cancer pain care therefore requires moving beyond pharmacological availability toward routine assessment of patient barriers, culturally sensitive communication, individualized education, supported self-management, and professionally guided non-pharmacological strategies. This Perspective reframes patient-related barriers as a central clinical, educational, and policy target in cancer pain care, arguing that health services should institutionalize barrier screening, communication training, risk-based follow-up, and audits that evaluate not only pain intensity, but also treatment understanding, adherence, and communicative barriers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.